Status:
ACTIVE_NOT_RECRUITING
Non-invasive Ventilation in Preterm Infants
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Premature Birth
Respiratory Distress Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a prospective, observational cohort study. For the study part on noninvasive neurally adjusted ventilatory assist (NIV-NAVA) the design is interventional. For all participants prospective data...
Eligibility Criteria
Inclusion
- Preterm infants (\< 37 weeks GA) supported with non-invasive respiratory support for at least 24 hours. Non-invasive respiratory support can consist of non-invasive NAVA, nasal continuous positive airway pressure (nCPAP) or high flow nasal canula (flow \> 2 liters/min).The support can be given as primary respiratory support or as respiratory support after weaning from invasive ventilation (= after extubation).
- Infants can only be enrolled after written and signed informed consent by the parents.
Exclusion
- Infant born after a gestational age of 37 weeks or more.
- Infants with major congenital malformations or chromosomal abnormalities (eg trisomy 18, congenital diaphragmatic hernia…)
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05987800
Start Date
February 1 2023
End Date
September 30 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium, 1090